EMA committee recommends approval of Novartis drug Votubia for non ... pharmabiz.com Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Votubia (everolimus) tablets for the treatment of adult patients with renal angiomyolipoma ... CHMP backs trio of Novartis products |
